| 摘要 |
Imidazol[1,2-a]quinoxalinone derivatives of general formula (I) wherein R<1>, R<2>, R<3> are the same or independently are H, alkyl, alkoxy, halogen, NO2, NH2, CF3, CN, SO2CH3, SO2CF3, SO2NR'R" or a 5- or 6- membered N-containing heterocyclic ring, optionally substituted, and R', R" are independently H or alkyl; and R<4> is H or CH2-R<6>; and R<6> is H, halogen, POR'''R'''', NR<7>R<8> or a 5- or 6-membered N-containing heterocyclic ring optionally substituted, and R''', R'''' are independently hydroxy or alkoxy; and R<7>, R<8> are the same or independently are H, (a) or alkyl optionally substituted; and n is 1, 2, or 3; (b), CH2OH, CHNOH, CN, (c) or (d) and R<9> is OH, alkoxy, H or NR<10>R<11>; and R<10>, R<11> are the same or independently are H, NH2 or OH; and X is O or S; and Y is O, S or NH2, and pharmaceutically acceptable salts thereof, have affinity for the AMPA receptors and are antagonists in connection with this type of receptor which makes them useful in the treatment of CNS ailments, especially in the treatment of any of the numerous indications caused by hyperactivity of excitatory amino acids.
|
